Atlas Trials

Can Albumin/C-reactive Protein Ratio be Utilized for Predicting Gestational Diabetes Diagnosis or the Adverse Outcomes

Clinical trial NCT06761053 · COMPLETED

Trial details

NCT number
NCT06761053
Sponsor
ALI BAHADIRLI
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Gestational Diabetes Mellitus in Pregnancy
Start date
2021-02-03
Primary completion
2022-02-03
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.